BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26084260)

  • 1. Pioglitazone in adult rats reverses immediate postnatal overfeeding-induced metabolic, hormonal, and inflammatory alterations.
    Boullu-Ciocca S; Tassistro V; Dutour A; Grino M
    Endocrine; 2015 Dec; 50(3):608-19. PubMed ID: 26084260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal programming of glucocorticoid metabolism in rats modulates high-fat diet-induced regulation of visceral adipose tissue glucocorticoid exposure and sensitivity and adiponectin and proinflammatory adipokines gene expression in adulthood.
    Boullu-Ciocca S; Achard V; Tassistro V; Dutour A; Grino M
    Diabetes; 2008 Mar; 57(3):669-77. PubMed ID: 18057089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postnatal diet-induced obesity in rats upregulates systemic and adipose tissue glucocorticoid metabolism during development and in adulthood: its relationship with the metabolic syndrome.
    Boullu-Ciocca S; Dutour A; Guillaume V; Achard V; Oliver C; Grino M
    Diabetes; 2005 Jan; 54(1):197-203. PubMed ID: 15616029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A post-weaning fish oil dietary intervention reverses adverse metabolic outcomes and 11β-hydroxysteroid dehydrogenase type 1 expression in postnatal overfed rats.
    Dai Y; Yang F; Zhou N; Sha L; Zhou S; Wang J; Li X
    Br J Nutr; 2016 Nov; 116(9):1519-1529. PubMed ID: 27819216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
    Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
    J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity.
    Liu J; Wang L; Zhang A; Di W; Zhang X; Wu L; Yu J; Zha J; Lv S; Cheng P; Hu M; Li Y; Qi H; Ding G; Zhong Y
    Endocr J; 2011; 58(3):199-209. PubMed ID: 21325744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes.
    Nakano S; Inada Y; Masuzaki H; Tanaka T; Yasue S; Ishii T; Arai N; Ebihara K; Hosoda K; Maruyama K; Yamazaki Y; Shibata N; Nakao K
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1213-22. PubMed ID: 17190905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 11β-HSD1 by LG13 improves glucose metabolism in type 2 diabetic mice.
    Zhao L; Pan Y; Peng K; Wang Z; Li J; Li D; Tong C; Wang Y; Liang G
    J Mol Endocrinol; 2015 Oct; 55(2):119-31. PubMed ID: 26220348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
    Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes.
    Tagawa N; Kubota S; Kato I; Kobayashi Y
    J Endocrinol; 2013 Sep; 218(3):311-20. PubMed ID: 23814014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of hepatic 11β-hydroxysteroid dehydrogenase-1 expression in calcium-deficient rats.
    Takaya J; Iharada A; Okihana H; Kaneko K
    Ann Nutr Metab; 2011; 59(2-4):73-8. PubMed ID: 22142627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetic effects of 11beta-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis.
    Lloyd DJ; Helmering J; Cordover D; Bowsman M; Chen M; Hale C; Fordstrom P; Zhou M; Wang M; Kaufman SA; Véniant MM
    Diabetes Obes Metab; 2009 Jul; 11(7):688-99. PubMed ID: 19527482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
    Wang M
    Handb Exp Pharmacol; 2011; (203):127-46. PubMed ID: 21484570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal overfeeding induced by small litter rearing causes altered glucocorticoid metabolism in rats.
    Hou M; Liu Y; Zhu L; Sun B; Guo M; Burén J; Li X
    PLoS One; 2011; 6(11):e25726. PubMed ID: 22073140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
    Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M
    J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid reduces glucocorticoid sensitivity in C2C12 myotubes by decreasing 11beta-hydroxysteroid dehydrogenase type 1 and glucocorticoid receptor activities.
    Aubry EM; Odermatt A
    Endocrinology; 2009 Jun; 150(6):2700-8. PubMed ID: 19179438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evaluation of adipose dysfunction via 11β-hydroxysteroid dehydrogenase type 1 in the development of diabetes in diet-induced obese mice with cortisone pellet implantation.
    Akiyama N; Akiyama Y; Kato H; Kuroda T; Ono T; Imagawa K; Asakura K; Shinosaki T; Murayama T; Hanasaki K
    J Pharmacol Exp Ther; 2014 Apr; 349(1):66-74. PubMed ID: 24511146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins.
    Kannisto K; Pietiläinen KH; Ehrenborg E; Rissanen A; Kaprio J; Hamsten A; Yki-Järvinen H
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4414-21. PubMed ID: 15356040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adipose tissue endocrine mechanism of the prophylactic protective effect of pioglitazone in high-fat diet-induced insulin resistance.
    Gong Y; Li J; Li C; Mu Y; Xiao Y; Tian H; Pan C; Liu Y
    J Int Med Res; 2012; 40(4):1304-16. PubMed ID: 22971482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.